Anglais

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

1 Formulaires  
Characterization of study population for prospective clinical trials
Description

Characterization of study population for prospective clinical trials

Alias
UMLS CUI-1
C2348561
UMLS CUI-2
C1880022
UMLS CUI-4
C0008976
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
Description

Biomarkers Serologic

Type de données

text

Alias
UMLS CUI [1,1]
C0005516
UMLS CUI [1,2]
C0205473
Composite scores: Either ACQ or ACT
Description

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Type de données

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Description

Exacerbation of asthma

Type de données

text

Alias
UMLS CUI [1]
C0349790
History of:
Description

Utilization healthcare; Costs healthcare

Type de données

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
Pulmonary physiology: Spirometry (pre­ and post­ bronchodilator)
Description

Spirometry

Type de données

text

Alias
UMLS CUI [1]
C0037981
Prospective clinical trial efficacy/ effectiveness outcomes
Description

Prospective clinical trial efficacy/ effectiveness outcomes

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1280519
Composite Scores: Either ACQ or ACT
Description

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Type de données

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Description

Exacerbation of asthma

Type de données

text

Alias
UMLS CUI [1]
C0349790
History of:
Description

Utilization healthcare; Costs healthcare

Type de données

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Description

medication asthma

Type de données

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Physiology Pulmonary: Spirometry (without bronchodilator)
Description

Spirometry

Type de données

text

Alias
UMLS CUI [1]
C0037981
Observational study outcomes
Description

Observational study outcomes

Alias
UMLS CUI-1
C1518527
UMLS CUI-2
C0086749
Composite Scores: Either ACQ or ACT
Description

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Type de données

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Description

Exacerbation of asthma

Type de données

text

Alias
UMLS CUI [1]
C0349790
History of:
Description

Utilization healthcare; Costs healthcare

Type de données

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Description

medication asthma

Type de données

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Physiology Pulmonary: Spirometry (pre­ and post­ bronchodilator)
Description

Spirometry

Type de données

text

Alias
UMLS CUI [1]
C0037981
Retour au début de la page

Similar models

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Characterization of study population for prospective clinical trials
C2348561 (UMLS CUI-1)
C1880022 (UMLS CUI-2)
C0008976 (UMLS CUI-4)
Biomarkers Serologic
Item
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
text
C0005516 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
Item
Composite scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Composite Scores
Code List
Composite scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions (1)
CL Item
Asthma­-specific ED visits (2)
CL Item
Asthma-­specific outpatient visits (3)
CL Item
Asthma-­specific medication use (4)
Spirometry
Item
Pulmonary physiology: Spirometry (pre­ and post­ bronchodilator)
text
C0037981 (UMLS CUI [1])
Item Group
Prospective clinical trial efficacy/ effectiveness outcomes
C0008976 (UMLS CUI-1)
C1280519 (UMLS CUI-2)
Item
Composite Scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Composite Scores
Code List
Composite Scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma, for at least 3 days (1)
CL Item
Asthma-­specific hospital admissions (2)
CL Item
 Asthma-­specific ED visits (separate UC visits when these can be differentiated) (3)
CL Item
Asthma-­specific ICU admissions/intubations (4)
CL Item
 Death (all cause and asthma related) (5)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Spirometry
Item
Physiology Pulmonary: Spirometry (without bronchodilator)
text
C0037981 (UMLS CUI [1])
Item Group
Observational study outcomes
C1518527 (UMLS CUI-1)
C0086749 (UMLS CUI-2)
Item
Composite Scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Composite Scores
Code List
Composite Scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Spirometry
Item
Physiology Pulmonary: Spirometry (pre­ and post­ bronchodilator)
text
C0037981 (UMLS CUI [1])
Retour au début de la page